Podcasts | Interviews
The Clinical Takeaway: Psilocybin vs escitalopram for depression, recent trial findings

The Clinical Takeaway: Psilocybin vs escitalopram for depression, recent trial findings

Description

In this episode:

 

– A recent study Prof David Nutt was involved in pitted psilocybin against escitalopram in a cleverly designed equipoise randomised controlled trial
– Results showed very rapid improvement (days rather than weeks) of depression symptoms and significantly better scores in wellbeing and depression in patients given psilocybin
– Whilst it is clear more studies are needed, there is growing interest in the use of psychedelic agents in the treatment of depression amongst younger and trainee psychiatrists, psychotherapists, and the general public
– As GPs, we should be aware of developments in this area

 

 

 

Host: Dr David Lim, GP and Medical Educator

 

Total time: 32 mins

 

Guest: Prof David Nutt, Neuropsychopharmacologist; Director of the Neuropsychopharmacology Unit; Division of Brain Sciences; Imperial College, London
 

 
 
 
 
 
 

 

Log your own CPD by following these easy steps:
– Listen to 30 minutes of Healthed podcasts
– Click on the Quick Log logo and follow the link to the RACGP website
– Log in to your myCPD dashboard
– Click on the Quick Log function to log your points
– A 30 minute podcast earns 1 CPD point

 

 

 

Enjoy this content?
Each fortnight, Healthed hosts a free webcast featuring leading experts on important topics for healthcare professionals. Register for the upcoming webcast by clicking the button below.

Register for the free webcast



Send this to a friend